Tidal Investments’s Takeda Pharmaceutical TAK Stock Holding History

Tidal Investments’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$955K	Sell	59,554 -1,060	-2%	-$17.5K	﹤0.01%	1767
2026 Q1	$1.12M	Hold	60,614	–	–	﹤0.01%	1418
2025 Q4	$945K	Sell	60,614 -31,032	-34%	-$444K	﹤0.01%	1303
2025 Q3	$1.34M	Hold	91,646	–	–	﹤0.01%	1075
2025 Q2	$1.42M	Buy	+91,646	New	+$1.35M	0.01%	871
2023 Q4	–	Sell	-10,223	Closed	-$158K	–	1517
2023 Q3	$158K	Buy	+10,223	New	+$158K	﹤0.01%	1246

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Tidal Investments's TAK Position: Q2 2026 in Review

Tidal Investments reduced its Takeda Pharmaceutical (TAK) stake by 1.7% in Q2 2026, selling an estimated $17.5K and leaving 59,554 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

Tidal Investments first reported a position in TAK in Q3 2023 and has held it in 6 quarters since. The position peaked at $1.42M in Q2 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Tidal Investments held 59,554 shares of Takeda Pharmaceutical worth $955K as of Q2 2026.
Tidal Investments sold 1,060 Takeda Pharmaceutical shares in Q2 2026, an estimated $17.5K.
Takeda Pharmaceutical made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1767 holding.
Tidal Investments first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 6 quarters since.
Tidal Investments's Takeda Pharmaceutical position peaked at $1.42M in Q2 2025.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.